Feed
Isomorphic Labs Raises $5 Billion Series C From Greenoaks, Sequoia
Funding

Isomorphic Labs Raises $5 Billion Series C From Greenoaks, Sequoia

17 Nov 2026, 6:12 pm · 3d ago · 1 min read · OfficeChai

Amount
$5B
Stage
Series C

Alphabet-backed drug discovery company Isomorphic Labs has secured $5 billion in a Series C funding round featuring Greenoaks Capital and Sequoia Capital. Spun out of Google's AI research lab DeepMind by founder Demis Hassabis, Isomorphic Labs leverages advanced artificial intelligence models to predict molecular behavior and radically accelerate pharmaceutical research. The massive capital infusion highlights surging institutional confidence in computational biology and generative AI for healthcare. The company plans to use the funds to advance its internal pipeline of AI-designed therapeutic candidates and expand high-value research partnerships with leading global biopharma companies.